| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response.
|
Hepatology
|
2010
|
2.44
|
|
2
|
Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin.
|
Hepatology
|
2002
|
1.89
|
|
3
|
Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B.
|
Clin Gastroenterol Hepatol
|
2010
|
1.60
|
|
4
|
Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C.
|
J Hepatol
|
2011
|
1.55
|
|
5
|
Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics.
|
Hepatology
|
2005
|
1.40
|
|
6
|
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1.
|
Gastroenterology
|
2010
|
1.35
|
|
7
|
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.
|
J Hepatol
|
2005
|
1.30
|
|
8
|
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
|
Clin Gastroenterol Hepatol
|
2006
|
1.21
|
|
9
|
Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis.
|
Gastroenterology
|
2010
|
1.18
|
|
10
|
Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine.
|
Vaccine
|
2006
|
1.08
|
|
11
|
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
|
Gastroenterology
|
2007
|
1.06
|
|
12
|
Dynamic transperineal ultrasound in the diagnosis of pelvic floor disorders: pilot study.
|
Dis Colon Rectum
|
2002
|
0.91
|
|
13
|
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.
|
World J Gastroenterol
|
2011
|
0.90
|
|
14
|
Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics.
|
Liver Int
|
2014
|
0.90
|
|
15
|
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study.
|
BMC Gastroenterol
|
2012
|
0.84
|
|
16
|
Methylprednisolone-induced liver injury: a diagnostic challenge.
|
Isr Med Assoc J
|
2014
|
0.82
|
|
17
|
Constant serum levels of secreted asialoglycoprotein receptor sH2a and decrease with cirrhosis.
|
World J Gastroenterol
|
2011
|
0.81
|
|
18
|
Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: a report of 9 cases.
|
Hepatology
|
2003
|
0.80
|
|
19
|
Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.
|
Liver Int
|
2006
|
0.78
|
|
20
|
Occult HBV infection--both hidden and mysterious.
|
Gastroenterology
|
2003
|
0.77
|
|
21
|
Pathogenesis of sodium retention in preascites: have we reached the heart of the problem?
|
Gastroenterology
|
2003
|
0.77
|
|
22
|
A secreted form of the asialoglycoprotein receptor, sH2a, as a novel potential noninvasive marker for liver fibrosis.
|
PLoS One
|
2011
|
0.76
|
|
23
|
"A la carte" treatment of portal hypertension or just "hors d'oeuvres".
|
Gastroenterology
|
2003
|
0.75
|
|
24
|
Treatment of chronic HCV--should we stop treating nonresponders?
|
Gastroenterology
|
2004
|
0.75
|
|
25
|
Nonhealing gastric ulcer caused by chronic alendronate administration.
|
MedGenMed
|
2002
|
0.75
|
|
26
|
Primary sclerosing cholangitis: a premalignant condition.
|
Gastroenterology
|
2002
|
0.75
|
|
27
|
Streptococcus bovis bacteremia associated with acute cholecystitis.
|
J Clin Gastroenterol
|
2006
|
0.75
|
|
28
|
[Autoimmune hepatitis].
|
Harefuah
|
2009
|
0.75
|